Trial intelligence / Profile preview

Tardive Dyskinesia and Cognitive Function

NCT00926965Phase 4Completed

Sponsor
Taipei Veterans General Hospital
Start
Jan 2003
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olanzapine, amisulpride in tardive dyskinesia (TD), sponsored by Taipei Veterans General Hospital. Started Jan 2003; status: completed.

02

Drugs

olanzapineamisulpride
03

Conditions

tardive dyskinesia (TD)

Beyond the preview

Go deeper on NCT00926965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00926965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call